600 patients66,869 observations120 daysLIVE

Patient P-01777

Synthetic patientNBL-101 · Day 98 · 45–54 · M · baseline S14Open companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Unstable
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
88%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 47 SC-12 recommendedSupportive Compound SC-12
  3. Day 48 Patient acceptedStarted SC-12 in the companion
  4. Day 50 Trajectory diverged from predictionObserved response fell below the model's expected path.
  5. Day 54 GI symptom burden −21% vs expectedSupportive Compound SC-12
  6. Day 60 Tolerance state changedUnstable → Improving
  7. Day 66 ME-01 recommendedMonitoring Escalation ME-01
  8. Day 67 Patient acceptedStarted ME-01 in the companion
  9. Day 70 Deterioration detected before clinical escalationMonitoring Escalation ME-01

What changed?

Trajectory began diverging from predicted response on Day 50.

Primary contributors, last 14 days
  • Nutritional resilience+11
  • Inflammatory activity-9
  • Toxicity-5
  • GI instability+3
  • Treatment adherence-2

What helped?

  • Supportive Compound SC-12Day 47
    Result: symptom burden −21%
  • Monitoring Escalation ME-01Day 66
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
GI Support Protocol GI-04
89%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 80
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 58 and rising
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 22/100
    • Daily logFibre intake low in recent food logs
  • Inflammatory signalling 45
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 47
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.7 · butyrate capacity 22/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
40 ms
Sleep
6.9 h
Steps
7,554
Resting HR
72 bpm
Daily log: GI score 58, nutritional resilience 49, adherence 50.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0149456%S14GI-04improved42
P-0178254%S14NP-02no change48
P-0140952%S14SC-12improved41
P-0183452%S14NP-02improved44
P-0189151%S14SC-12improved41
P-0170950%S14GI-04improved43
P-0159549%S14GI-04no change51
P-0160349%S14GI-04improved40
P-0178149%S14NP-02improved45
P-0136048%S14GI-04improved52
P-0142948%S09GI-04improved45
P-0184348%S14SC-12no change45